Modern chemotherapy methods in prostate cancer, bladder and testicular cancer treatment, determining the need for adjuvant and non-adjuvant chemotherapy
Innovative immunological treatment of bladder cancer of the 4th stage
The combination of hormone therapy and radiation in metastatic prostate cancer treatment
Biological treatment of metastatic kidney cancer and determining the need for its combination with IGRT radiotherapy
Determining the possibility of breast cancer conservative surgery and the need for pre- and postoperative chemotherapy, as well as its combination with radiotherapy
Dr. Victoriia Neiman is an excellent oncologist, great doctor and simply warm-hearted person. We involve her for consulting difficult patients. Dr. Neiman is focused on complex treating of female urogenital system tumors. She is one of acknowledged authorities in breast cancer treating in Israel.
Dr. Neiman is a sensitive and attentive doctor and person who treat her patients with sincere care. Everybody who visits Dr. Victoriia Neiman has a chance to get rid of oncological disease forever.
Participation of Victoriia Neiman in scientific researches:
2000 г. -«Evidence of Fer94 gene in malignant limphadenoids» — research based at molecular biology laboratory of Bar-Ilan University (Israel) together with Dr. Uri Niv.
Since 2001 till present — Principal Investigator of the 2nd and 3rd stage of clinical researches in the field of urogenital system tumors.
Since 2001 till present — Principal Investigator of the 2nd and 3rd stage of clinical researches in the field of breast tumors.
In 2006 Dr. Neiman completed a course in «Appropriate clinical practice in clinical rsearches» (ICH-GCP).
Professional and academical practice of Dr. Victoriia Neiman:
Teaching in groups of medical students at Sackler Medical College as a part of Tel Aviv University.
Teaching within the framework of medical program refresher course for repatriate doctors at Rabin Medical Center.
Teaching at Nurse College of Rabin Medical Center.
Teaching at postgraduate education courses for family doctors at Tel Aviv University.
Member of Israeli medical attestation commission of the 1st and 2nd stage in the field of therapy.
Member of Israeli medical attestation commission of the 1st and 2nd stage in the field of oncology and radiation therapy.
Victoriia Neiman is a member of:
Israeli Society of General Therapy,
Israeli Society of Urology,
Israeli Society of Clinical Oncology and Radiation Therapy,
European Society for Medical Oncology.
“Outcome of Patients with Metastatic Chromophobe Renal Cell Carcinoma treated with Sunitinib”, - The Oncologist, July 2016. Co-authors: D. Keizman, D. Sarid, J. L. Lee, I. Yildiz
“Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations”, - Breast Cancer Research and Treatment, May 2016. Co-authors: R. Lewin, A. Sulkes, T. Shochat, R. Yerushalmi
“Metformin use and outcome of sunitinib treatment in diabetic patients with metastatic renal cell carcinoma”, - Clinical Genitourinary Cancer, April 2016
«Активность Кабизитаксела после терапии препаратами Доцетаксел и Абиратерона Ацетат у пациентов с раком простаты типа CRPC», - Журнал «Клинический мочеполовой рак», декабрь 2014 («Activity of Cabazitaxel After Docetaxel and Abiraterone Acetate Therapy in Patients With Castration-Resistant Prostate Cancer», - Clinical Genitourinary Cancer, December 2014) Соавторы: Avishay Sella · Tal Sella · Avivit Peer ·Daniel Keizman
Адъювантная терапия препаратами Доцетаксел и Циклофосфамид с профилактическим гранулоцетарным колониеобразующим фактором на 8 и 12 день у пациенток с раком молочной железы: Ретроспективный анализ», - Журнал «Общественной научной библиотеки«, октябрь 2014 («Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 & 12 in Breast Cancer Patients: A Retrospective Analysis», - Public Library of Science Journal, October 2014) Соавторы: Rinat Yerushalmi · Hadar Goldvaser · Aaron Sulkes · Salomon M Stemmer
Персонифицированный скрининг рака предстательной железы у мужчин с высокой генетической предрасположенностью: протокол исследования для перспективнойго когортного изучения«, - Журнал «BMC Cancer», июль 2014 («Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study», - BMC Cancer, July 2014) Соавторы: David Margel · Ofer Benjaminov · Rachel Ozalvo · Eli Rosenbau